Nuclear matrix proteins as proteomic markers of preneoplastic and cancer lesions

Clinical Cancer Research

Volumn 8, Issue 10, 2002, Pages 3031-3033

  Coffey, Donald S ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR PROTEIN; TUMOR MARKER;

CANCER; CANCER THERAPY; CELL NUCLEUS MATRIX; CHROMOSOME REARRANGEMENT; COLON CANCER; DNA REPAIR; DNA REPLICATION; DNA SEQUENCE; EARLY DIAGNOSIS; LIVER METASTASIS; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; SHORT SURVEY;

HUMANS; NUCLEAR MATRIX-ASSOCIATED PROTEINS; PRECANCEROUS CONDITIONS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036793786     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (24)

1. Pienta, K., Partin, A., and Coffey, D. Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res., 49: 2525-2532, 1989.
2. Getzenberg, R., Pienta, K., Huang, E., and Coffey, D. Identification of nuclear matrix proteins in the cancer and normal rat prostate. Cancer Res., 51: 6514-6520, 1991.
3. Boyd, J., Pienta, K., Getzenberg, R., Coffey, D., and Barrett, J. Preneoplastic alterations in nuclear morphology that accompany loss of tumor suppressor phenotype. J. Natl. Cancer Inst., 83: 862-866, 1991.
4. Partin, A., Steinberg, G., Pitcock, R., Wu, L., Piantadosi, S., Coffey, D., and Epstein, J. Use of nuclear morphometry, Gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer. Cancer (Phila.), 70: 162-168, 1992.
5. Mohler, J., Partin, A., Epstein, J., Becker, R., Mikel, U., Sesterhenn, I., Mostofi, F., Gleason, D., Sharief, Y., and Coffey, D. Prediction of prognosis in untreated stage A2 prostatic carcinoma. Cancer (Phila.), 69: 511-519, 1992.
6. Berezney, R., and Coffey, D. Nuclear Matrix. Isolation and characterization of a framework structure from rat liver nuclei. J. Cell Biol., 73: 616-637, 1977.
7. Fey, E., and Penman, S. Nuclear matrix protein reflects cell type of origin in cultured human cells. Proc. Natl. Acad of Science USA, 85: 121-125, 1988.
8. Getzenberg, R., Pienta, K., and Coffey, D. The tissue matrix: cell dynamics and hormone action. Endocr. Rev., 11: 399-417, 1990.
9. Takaha, N., Hawkins A., Griffin, C., Isaacs, W., and Coffey, D. High mobility group protein I(Y): a candidate architectural protein for chromosomal rearrangements in prostate cancer cells. Cancer Res., 62: 647-651, 2002.
10. Razin, S. Chromosomal DNA loop constitutes basic unit of the eukaryotic genome organization to evolution. Crit. Rev. Eucaryote Gene Expression, 9: 279-283, 1999.
11. Pienta, K., and Coffey, D. Nuclear-cytoskeletal interactions: evidence for physical connections between the nucleus and cell periphery and their alteration by transformation. J. Cell. Biochem., 49: 357-365, 1992.
12. Pienta, K., Getzenberg, R., and Coffey, D. Cell structure and DNA organization. Crit. Rev. Eukaryotic Gene Expression, 1: 355-385, 1991.
13. Misteli, T., and Spector, D. The cellular organization of gene expression. Curr. Opin. Cell Biol., 10: 322-332, 1998.
14. Vogelstein, B., Pardoll, D., and Coffey, D. Supercoiled loops and eucaryotic DNA replication. Cell, 22: 79-85, 1980.
15. Berezney, R., and Coffey, D. Nuclear protein matrix: association with newly synthesized DNA. Science (Wash. DC), 189: 291-293, 1975.
16. Ward, W., Partin, A., and Coffey, D. DNA Loop domains in mammalian spermatozoa. Chromosoma, 98: 153-159, 1989.
17. Partin, A., Getzenberg, R., Carmichael, M., Vindivich, D., Yoo, J., Epstein, J., and Coffey, D. Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res., 53: 744-746, 1993.
18. Koney, B., Nangia, A., Nguyen, T., Veitmeier, B., Dhir, R., Acierno, J., Becich, M., Hrebinko, R., and Getzenberg, R. Identification of nuclear matrix protein alterations associated with renal cell carcinoma. J. Urol., 159: 1359-1363, 1998.
19. Getzenberg, R., Konety, B., Oeler, T., Quigley, M., Hakam, A., Becich, M., and Bahnson, R. Bladder cancer-associated nuclear matrix proteins. Cancer Res., 56: 1690-1694, 1996.
20. Brunagel, G., Vietmeier, B., Bauer, A., Schoen, R., and Getzenberg, R. Identification of nuclear matrix protein alterations associated with human colon cancer. Cancer Res., 62: 2437-2442, 2002.
21. Konety, B. R., Nguyen, T. T., Dhir, R., Day, R. S., Becich, M. J., Stadler, W. M., and Getzenberg, R. H. Detection of bladder cancer using a novel nuclear matrix protein. Clin. Cancer Res., 6: 2618-2625, 2000.
22. Miller, T., Beausang, L., Winchell, L., and Lidgard, G. Detection of nuclear matrix proteins in serum from cancer patients. Cancer Res., 52: 422-427, 1992.
23. Coffey, D. Self-organization, complexity and chaos: the new biology for medicine. Nat. Med., 4: 882-885, 1998.
24. Burdette, W. J. The significance of mutation in relation to origins of tumors. A review. Cancer Res., 15: 201-226, 1955.